Allovir Inc

Company Profile

Allovir Inc had its IPO on 2020-07-30 under the ticker symbol ALVR.

The company operates in the Healthcare sector and Biotechnology industry. Allovir Inc has a staff strength of 106 employees.

Stock update

Shares of Allovir Inc opened at $2.81 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.65 - $2.87, and closed at $2.66.

This is a -6.34% slip from the previous day's closing price.

A total volume of 642,880 shares were traded at the close of the day’s session.

In the last one week, shares of Allovir Inc have slipped by -17.39%.

Allovir Inc's Key Ratios

Allovir Inc has a market cap of $506.57 million, indicating a price to book ratio of 2.465 and a price to sales ratio of 0.

In the last 12-months Allovir Inc’s revenue was $0 with a gross profit of $165000 and an EBITDA of $-170479008. The EBITDA ratio measures Allovir Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Allovir Inc’s operating margin was 0% while its return on assets stood at -37.97% with a return of equity of -75.02%.

In Q4, Allovir Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Allovir Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.96 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Allovir Inc’s profitability.

Allovir Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -2.0543. Its price to sales ratio in the trailing 12-months stood at 0.

Allovir Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$277.08 million

Total Liabilities

$24.34 million

Operating Cash Flow

$13.54 million

Capital Expenditure

$0

Dividend Payout Ratio

0%

Allovir Inc ended 2024 with $277.08 million in total assets and $0 in total liabilities. Its intangible assets were valued at $277.08 million while shareholder equity stood at $224.52 million.

Allovir Inc ended 2024 with $0 in deferred long-term liabilities, $24.34 million in other current liabilities, 9000.00 in common stock, $-465775000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $106.09 million and cash and short-term investments were $233.80 million. The company’s total short-term debt was $7,165,000 while long-term debt stood at $0.

Allovir Inc’s total current assets stands at $243.05 million while long-term investments were $0 and short-term investments were $127.70 million. Its net receivables were $157000.00 compared to accounts payable of $3.00 million and inventory worth $0.

In 2024, Allovir Inc's operating cash flow was $13.54 million while its capital expenditure stood at $0.

Comparatively, Allovir Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.66

52-Week High

$10.29

52-Week Low

$3.17

Analyst Target Price

$22

Allovir Inc stock is currently trading at $2.66 per share. It touched a 52-week high of $10.29 and a 52-week low of $10.29. Analysts tracking the stock have a 12-month average target price of $22.

Its 50-day moving average was $3.13 and 200-day moving average was $4.62 The short ratio stood at 18.79 indicating a short percent outstanding of 0%.

Around 4986.3% of the company’s stock are held by insiders while 4063.9% are held by institutions.